These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 1717717)

  • 81. Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody B12 that effectively targets the site of CD4 attachment.
    Wu X; Zhou T; O'Dell S; Wyatt RT; Kwong PD; Mascola JR
    J Virol; 2009 Nov; 83(21):10892-907. PubMed ID: 19692465
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Immune escape by human immunodeficiency virus type 1 from neutralizing antibodies: evidence for multiple pathways.
    Watkins BA; Reitz MS; Wilson CA; Aldrich K; Davis AE; Robert-Guroff M
    J Virol; 1993 Dec; 67(12):7493-500. PubMed ID: 7693973
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Further characterization of an antigenic site of HIV-1 gp120 recognized by virus neutralizing human monoclonal antibodies.
    Schutten M; McKnight A; Huisman RC; Thali M; McKeating JA; Sodroski J; Goudsmit J; Osterhaus AD
    AIDS; 1993 Jul; 7(7):919-23. PubMed ID: 7689324
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Characterization of a discontinuous epitope of the HIV envelope protein gp120 recognized by a human monoclonal antibody using chemical modification and mass spectrometric analysis.
    Hager-Braun C; Hochleitner EO; Gorny MK; Zolla-Pazner S; Bienstock RJ; Tomer KB
    J Am Soc Mass Spectrom; 2010 Oct; 21(10):1687-98. PubMed ID: 20434359
    [TBL] [Abstract][Full Text] [Related]  

  • 85. An investigation of the high-avidity antibody response to glycoprotein 120 of human immunodeficiency virus type 1.
    Binley JM; Arshad H; Fouts TR; Moore JP
    AIDS Res Hum Retroviruses; 1997 Aug; 13(12):1007-15. PubMed ID: 9264287
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles.
    Gorny MK; Stamatatos L; Volsky B; Revesz K; Williams C; Wang XH; Cohen S; Staudinger R; Zolla-Pazner S
    J Virol; 2005 Apr; 79(8):5232-7. PubMed ID: 15795308
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding.
    Olshevsky U; Helseth E; Furman C; Li J; Haseltine W; Sodroski J
    J Virol; 1990 Dec; 64(12):5701-7. PubMed ID: 2243375
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Simple enzyme immunoassay for titration of antibodies to the CD4-binding site of human immunodeficiency virus type 1 gp120.
    Turbica I; Posner M; Bruck C; Barin F
    J Clin Microbiol; 1995 Dec; 33(12):3319-23. PubMed ID: 8586727
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein.
    Skinner MA; Ting R; Langlois AJ; Weinhold KJ; Lyerly HK; Javaherian K; Matthews TJ
    AIDS Res Hum Retroviruses; 1988 Jun; 4(3):187-97. PubMed ID: 2456088
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Human monoclonal antibodies and engineered antibody domains as HIV-1 entry inhibitors.
    Chen W; Dimitrov DS
    Curr Opin HIV AIDS; 2009 Mar; 4(2):112-7. PubMed ID: 19339949
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Structure of a high-affinity "mimotope" peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodies.
    Saphire EO; Montero M; Menendez A; van Houten NE; Irving MB; Pantophlet R; Zwick MB; Parren PW; Burton DR; Scott JK; Wilson IA
    J Mol Biol; 2007 Jun; 369(3):696-709. PubMed ID: 17445828
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene.
    Takeuchi Y; Akutsu M; Murayama K; Shimizu N; Hoshino H
    J Virol; 1991 Apr; 65(4):1710-8. PubMed ID: 2002539
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Natural analogue peptides of an HIV-1 GP120 T-helper epitope antagonize response of GP120-specific human CD4 T-cell clones.
    Fenoglio D; Li Pira G; Lozzi L; Bracci L; Saverino D; Terranova P; Bottone L; Lantero S; Megiovanni A; Merlo A; Manca F
    J Acquir Immune Defic Syndr; 2000 Jan; 23(1):1-7. PubMed ID: 10708050
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain.
    Laman JD; Schellekens MM; Abacioglu YH; Lewis GK; Tersmette M; Fouchier RA; Langedijk JP; Claasen E; Boersma WJ
    J Virol; 1992 Aug; 66(8):5175. PubMed ID: 1629971
    [No Abstract]   [Full Text] [Related]  

  • 95. Reintroduction of the 2G12 epitope in an HIV-1 clade C gp120.
    Chen H; Xu X; Bishop A; Jones IM
    AIDS; 2005 May; 19(8):833-5. PubMed ID: 15867500
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope.
    Palker TJ; Matthews TJ; Clark ME; Cianciolo GJ; Randall RR; Langlois AJ; White GC; Safai B; Snyderman R; Bolognesi DP
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2479-83. PubMed ID: 2436231
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Computational identification of epitopes in the glycoproteins of novel bunyavirus (SFTS virus) recognized by a human monoclonal antibody (MAb 4-5).
    Zhang W; Zeng X; Zhang L; Peng H; Jiao Y; Zeng J; Treutlein HR
    J Comput Aided Mol Des; 2013 Jun; 27(6):539-50. PubMed ID: 23838839
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The highly conserved aspartic acid residue between hypervariable regions 1 and 2 of human immunodeficiency virus type 1 gp120 is important for early stages of virus replication.
    Wang WK; Essex M; Lee TH
    J Virol; 1995 Jan; 69(1):538-42. PubMed ID: 7983752
    [TBL] [Abstract][Full Text] [Related]  

  • 99. CD4 binding determinant mimicry for HIV vaccine design.
    Nishiyama Y; Planque S; Hanson CV; Massey RJ; Paul S
    Front Immunol; 2012; 3():383. PubMed ID: 23251137
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Conservation of HIV-1 gp120 neutralizing epitopes after formalin inactivation.
    Sattentau QJ
    AIDS; 1995 Dec; 9(12):1383-5. PubMed ID: 8605064
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.